Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Amphastar Pharmaceuticals Inc's Business Segments
Amphastar Pharmaceuticals Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Pharmaceutical products segment
Total Revenue
$ 171
Countrys Reported
3
Revenue Share by Reportable Segment - Q1 FY2026
- Pharmaceutical products segment100%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Pharmaceutical products segment | $ 171 | 100% |
Revenue Share by Country - Q1 FY2026
- US92.9%
- FR5.6%
- CN1.5%
Revenue by Geographic Country - Q1 FY2026
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 159 | 92.9% |
| FR | $ 10 | 5.6% |
| CN | $ 2 | 1.5% |
Description of Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc is a publicly traded American pharmaceutical company founded in 1996 by Drs. Jack and Rex Zhang. The company is headquartered in Rancho Cucamonga, California and has a market capitalization of over $1 billion. Amphastar specializes in the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products.
The company has more than 20 injectable products in its portfolio, which includes anesthesia, analgesics, anti-infectives, cardiovascular, and central nervous system agents. Amphastar's most significant revenue generating product is enoxaparin sodium injection, a generic version of Sanofi's anticoagulant Lovenox. This product accounts for more than 50% of the company's total revenue.
Additionally, Amphastar has branded products, such as Primatene Mist, an over-the-counter inhaler used for the treatment of asthma symptoms. The company also has a pipeline of innovative products, including products in clinical trials for diabetes, hypoglycemia, and severe allergies.
The company has three manufacturing facilities located in California, which are equipped with the latest manufacturing technology and conform to the highest regulatory standards of the FDA and the European Medicines Agency (EMA).
In addition to its manufacturing capabilities, Amphastar has a robust research and development team that is responsible for developing new products and improving existing products. The company invests heavily in research and development, spending around 20% of its revenue on these activities.
Amphastar has a global presence and has distribution partnerships in many countries, including the United States, Europe, and Asia. The company has a diverse customer base that includes hospitals, wholesalers, and distributors.
Amphastar is committed to corporate social responsibility and strives to reduce its impact on the environment. The company has implemented sustainability programs that focus on energy efficiency, water conservation, and waste management.
In summary, Amphastar Pharmaceuticals is a leading pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products. With a wide range of products, an innovative pipeline, and a strong commitment to sustainability, Amphastar is poised for continued growth and success in the pharmaceutical industry.
The company has more than 20 injectable products in its portfolio, which includes anesthesia, analgesics, anti-infectives, cardiovascular, and central nervous system agents. Amphastar's most significant revenue generating product is enoxaparin sodium injection, a generic version of Sanofi's anticoagulant Lovenox. This product accounts for more than 50% of the company's total revenue.
Additionally, Amphastar has branded products, such as Primatene Mist, an over-the-counter inhaler used for the treatment of asthma symptoms. The company also has a pipeline of innovative products, including products in clinical trials for diabetes, hypoglycemia, and severe allergies.
The company has three manufacturing facilities located in California, which are equipped with the latest manufacturing technology and conform to the highest regulatory standards of the FDA and the European Medicines Agency (EMA).
In addition to its manufacturing capabilities, Amphastar has a robust research and development team that is responsible for developing new products and improving existing products. The company invests heavily in research and development, spending around 20% of its revenue on these activities.
Amphastar has a global presence and has distribution partnerships in many countries, including the United States, Europe, and Asia. The company has a diverse customer base that includes hospitals, wholesalers, and distributors.
Amphastar is committed to corporate social responsibility and strives to reduce its impact on the environment. The company has implemented sustainability programs that focus on energy efficiency, water conservation, and waste management.
In summary, Amphastar Pharmaceuticals is a leading pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and proprietary injectable and inhalation products. With a wide range of products, an innovative pipeline, and a strong commitment to sustainability, Amphastar is poised for continued growth and success in the pharmaceutical industry.
Amphastar Pharmaceuticals Inc. Overview
Amphastar Pharmaceuticals Inc. is a prominent global biopharmaceutical company that specializes in creating and offering a diverse range of segments, products, and services aimed at meeting the health care needs of patients worldwide. The company’s commitment to high-quality standards and accessibility is foundational to its mission of enhancing patient outcomes through innovative research and practical applications in medicine.
Segments
1. Finished Pharmaceuticals:
Amphastars portfolio in this segment encompasses a wide variety of finished pharmaceutical products that target several medical conditions. The organizations offerings include:
- Injectables: These are products used in critical care settings, including anesthetic procedures and pain management. They ensure effective delivery of drugs directly into the bloodstream for rapid therapeutic effects.
- Inhalation Products: Designed for patients with respiratory conditions, these products facilitate rapid absorption of medication through the lungs, making them effective for various treatments.
2. Active Pharmaceutical Ingredients (APIs):
APIs represent a crucial segment of Amphastars operations, involving the production of active components that are essential for the formulation of pharmaceuticals. Amphastar not only manufactures these ingredients but also markets them to other pharmaceutical entities globally, positioning itself as a significant player in the supply chain.
3. Nasal Sprays and Topical Products:
The company has developed a range of nasal sprays and topical formulations designed to address specific medical ailments. For example, nasal sprays assist in treating allergies and sinus congestion, while topical products may be used for pain relief, demonstrating the company’s versatility in formulation technology.
Products
1. Epinephrine:
Amphastar manufactures several formulations of epinephrine for injection, crucial for addressing acute allergic reactions, particularly anaphylaxis. These products are essential in emergency medical settings.
2. Naloxone:
The company offers lifecycle-managed naloxone formulations that rapidly reverse opioid overdose effects, facilitating the restoration of normal respiratory function in patients.
3. Lidocaine:
Known for its numbing properties, Amphastar produces lidocaine injection products used effectively in anesthetic procedures, allowing for pain-free interventions.
4. Sodium Bicarbonate:
Their sodium bicarbonate products are essential for treating metabolic acidosis and other acid-base disturbances, providing vital support in critical care scenarios.
Services
1. Contract Manufacturing:
Amphastar extends its capabilities through contract manufacturing services that cater to pharmaceutical companies needing assistance with producing APIs, finished pharmaceutical products, and clinical supplies. This service offering facilitates greater efficiency and expertise for partners.
2. Research and Development:
The company maintains a robust R&D department dedicated to the innovation and improvement of therapeutic solutions. Ongoing projects include the development of new drug formulations and exploration of novel drug candidates, focusing on enhancing patient care and ensuring the adoption of cutting-edge medical treatments.
3. Regulatory Affairs:
Amphastar plays a vital role in helping pharmaceutical companies navigate the intricate regulatory landscape. Their expertise in regulatory affairs assists partners in achieving timely product approvals, ensuring compliance with health and safety standards.
Conclusion
Amphastar Pharmaceuticals Inc. stands out in the biopharmaceutical sector through its diverse range of segments, high-quality products, and comprehensive services. The company’s focus on innovation, stringent quality control, and commitment to affordable healthcare underscores its pivotal role in the global pharmaceutical industry. Its collaborations and partnerships are grounded in mutual goals of improving patient outcomes and advancing therapeutic measures across multiple dimensions of health care.
Amphastar Pharmaceuticals Inc. is a prominent global biopharmaceutical company that specializes in creating and offering a diverse range of segments, products, and services aimed at meeting the health care needs of patients worldwide. The company’s commitment to high-quality standards and accessibility is foundational to its mission of enhancing patient outcomes through innovative research and practical applications in medicine.
Segments
1. Finished Pharmaceuticals:
Amphastars portfolio in this segment encompasses a wide variety of finished pharmaceutical products that target several medical conditions. The organizations offerings include:
- Injectables: These are products used in critical care settings, including anesthetic procedures and pain management. They ensure effective delivery of drugs directly into the bloodstream for rapid therapeutic effects.
- Inhalation Products: Designed for patients with respiratory conditions, these products facilitate rapid absorption of medication through the lungs, making them effective for various treatments.
2. Active Pharmaceutical Ingredients (APIs):
APIs represent a crucial segment of Amphastars operations, involving the production of active components that are essential for the formulation of pharmaceuticals. Amphastar not only manufactures these ingredients but also markets them to other pharmaceutical entities globally, positioning itself as a significant player in the supply chain.
3. Nasal Sprays and Topical Products:
The company has developed a range of nasal sprays and topical formulations designed to address specific medical ailments. For example, nasal sprays assist in treating allergies and sinus congestion, while topical products may be used for pain relief, demonstrating the company’s versatility in formulation technology.
Products
1. Epinephrine:
Amphastar manufactures several formulations of epinephrine for injection, crucial for addressing acute allergic reactions, particularly anaphylaxis. These products are essential in emergency medical settings.
2. Naloxone:
The company offers lifecycle-managed naloxone formulations that rapidly reverse opioid overdose effects, facilitating the restoration of normal respiratory function in patients.
3. Lidocaine:
Known for its numbing properties, Amphastar produces lidocaine injection products used effectively in anesthetic procedures, allowing for pain-free interventions.
4. Sodium Bicarbonate:
Their sodium bicarbonate products are essential for treating metabolic acidosis and other acid-base disturbances, providing vital support in critical care scenarios.
Services
1. Contract Manufacturing:
Amphastar extends its capabilities through contract manufacturing services that cater to pharmaceutical companies needing assistance with producing APIs, finished pharmaceutical products, and clinical supplies. This service offering facilitates greater efficiency and expertise for partners.
2. Research and Development:
The company maintains a robust R&D department dedicated to the innovation and improvement of therapeutic solutions. Ongoing projects include the development of new drug formulations and exploration of novel drug candidates, focusing on enhancing patient care and ensuring the adoption of cutting-edge medical treatments.
3. Regulatory Affairs:
Amphastar plays a vital role in helping pharmaceutical companies navigate the intricate regulatory landscape. Their expertise in regulatory affairs assists partners in achieving timely product approvals, ensuring compliance with health and safety standards.
Conclusion
Amphastar Pharmaceuticals Inc. stands out in the biopharmaceutical sector through its diverse range of segments, high-quality products, and comprehensive services. The company’s focus on innovation, stringent quality control, and commitment to affordable healthcare underscores its pivotal role in the global pharmaceutical industry. Its collaborations and partnerships are grounded in mutual goals of improving patient outcomes and advancing therapeutic measures across multiple dimensions of health care.